ERC Launches Development Program for Novel Cell-Based Therapeutic and Prophylactic SARS-CoV-2 Vaccine

ISNES, Belgium, April 09, 2020 (GLOBE NEWSWIRE) -- ERC Worldwide today announced the launch of the Companys development program for its therapeutic and prophylactic vaccine against the new coronavirus SARS-CoV-2.